Compounds > n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine
Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and 3-iodobenzylguanidine

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with 3-iodobenzylguanidine in 1 studies

Compound Research Comparison

Studies
(n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine)		Trials
(n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine)		Recent Studies (post-2010)
(n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine)		Studies
(3-iodobenzylguanidine)		Trials
(3-iodobenzylguanidine)		Recent Studies (post-2010) (3-iodobenzylguanidine)
80213,5632601,054

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Polla, BS; Slosman, DO1

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and 3-iodobenzylguanidine

ArticleYear
MIBG versus HIPDM as a lung imaging agent.
    European journal of nuclear medicine, 1988, Volume: 14, Issue:12

    Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Iodobenzenes; Lung; Radionuclide Imaging

1988